CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
September 2021—As my term as president of the College of American Pathologists comes to a close, I am both honored and humbled to have been selected by my peers for this position. Over the past two years our organization was presented with the greatest challenge we have ever faced. Because of our phenomenal members and staff, we have accomplished great things even though we worked under the most adverse conditions. We, yet again, backed a horse named CAP. It broke out of the gate well and had to weave through traffic on a bad track, but we are ahead. We made the right bet and I am so, so lucky to have been chosen to be the jockey for this race.
Looking back, the COVID-19 pandemic presented our community with relatively sudden and profound changes resulting in a tremendous number of challenges. It has dominated our lives. We should be proud of our accomplishments. We have not only put out many fires and sewn up deep wounds, but we have also set up the College and our fellows for continued success so that we will be able to keep serving our patients well.
Dr. Godbey
Many, many people have said things to me such as, “I bet this wasn’t the presidency you expected. . . . I feel sorry for you.” Well, I would like to say how I feel. I believe that I am the most fortunate person to ever have had the opportunity to be president of this organization. No other president has been given the chance to champion pathologists and the laboratories we direct like I have. When I finish this column, I will talk with someone from the Wall Street Journal and then the New York Times. Sometimes they want to be educated, and sometimes they just want to run things by you. The important point is that they now call a pathologist first when they have questions. This is new. The pandemic gave us a chance to shine, and we are now considered by the press, by elected officials, by the FDA as well as the CMS to be an authority on testing. More than ever before, patients know who we are.
There have been many other issues that the CAP needed to address during my tenure as president. Early in my term, I worked with several of my CAP colleagues on the search for a new editor to entrust with our flagship journal, Archives of Pathology & Laboratory Medicine. Alain Borczuk, MD, has proved to be an excellent leader for the publication and will ensure that it maintains its sterling reputation among pathologists.
We have also pushed to improve committee structures and responsibilities within the CAP. We took steps to make our committee appointment process much more transparent. We developed a uniform application for these positions, and the information about our committees found on the website is much improved. By taking a close look at committee membership and involvement, we were able to make it possible for more fellows to serve in these important bodies.
I am proud that during my tenure the CAP, in no uncertain terms, took a stand against racism—all racism, of any kind, anywhere. In addition, the CAP, in no uncertain terms, took a stand against violence—all violence, of any kind, anywhere. We formed our first Diversity, Equity, and Inclusion Committee. It will take a long time to accomplish our DEI goals, but I have no doubt the CAP is going to do it right and create lasting change.
We found a new home for our Pathologists Quality Registry as a Qualified Clinical Data Registry, which is the first clinical data registry designed by pathologists for pathologists. The QCDR will now be overseen by the new Quality and Clinical Data Registry Affairs Committee.
We also improved the accreditation process, an important step in our ongoing mission to ensure the best quality across all clinical laboratories. Our Council on Accreditation had to find a way to make sure our inspection processes continued to assure quality while meeting the access challenges dealt by COVID-19. We achieved that, and the CAP continues to be the gold standard for laboratory accreditation throughout the world.